Could a hidden infection explain that thickened nuchal translucency?
NCT ID NCT05388968
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether infections might be linked to increased nuchal translucency, a marker seen on early pregnancy ultrasounds. Researchers used advanced genetic sequencing to look for viruses, bacteria, or parasites in placental tissue from 78 pregnant women. The goal was to see if hidden infections could be a cause, but this was an observational study, not a treatment trial.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that some cases of increased nuchal translucency are caused by infections, potentially leading to new screening or treatment approaches.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. It only looks for infections and does not test any therapy, so it cannot prove cause or offer direct benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
78 people
The number who actually took part.
- Started
-
Nov 2022
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Pregnant women consulting in the prenatal diagnosis Unit of the University Hospital Necker-Enfants-malades
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pregnant women * Singleton pregnancy * First trimester (11 GA+0D to 13 GA+6D) * Carrying a fetus with a nuchal translucency \> 3.5 mm for which a chorionic villi sampling is performed OR a suspicion of genetic abnormalities for which a chorionic villi sampling is performed * Delivery planned at Necker hospital * Not opposed to participation Exclusion Criteria * Age \<18 years * no health insurance * difficulties in understanding the French language * chronic infection (HIV, HBV, HVC and HTLV-1)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Increased nuchal translucency in the first trimester of pregnancy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Necker - Enfants malades
Paris, 75015, France